Cheng Xu

2.1k total citations · 1 hit paper
49 papers, 1.6k citations indexed

About

Cheng Xu is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Cheng Xu has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Physiology and 10 papers in Cancer Research. Recurrent topics in Cheng Xu's work include Peroxisome Proliferator-Activated Receptors (8 papers), Adipose Tissue and Metabolism (7 papers) and Metabolism, Diabetes, and Cancer (5 papers). Cheng Xu is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (8 papers), Adipose Tissue and Metabolism (7 papers) and Metabolism, Diabetes, and Cancer (5 papers). Cheng Xu collaborates with scholars based in China, United States and Portugal. Cheng Xu's co-authors include Jinqiu Zhang, Haisheng Peng, Shu‐Kun Tang, Xiaoying Liu, Qun Wang, Man Zhao, Wenhua Li, Wenyuan Zhang, Xuefu He and D. Bruce Harris and has published in prestigious journals such as Science, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Cheng Xu

48 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery

2021 545 citations Cheng Xu et al. profile →

Peers

Cheng Xu

MB

BIOMA

BE

CR

HTM

Jung‐Taek Kwon South Korea

Tingting Ding China

Kazuma Higashisaka Japan

Magdalena Skonieczna Poland

Xiaofei Qin China

Jen‐Kun Chen Taiwan

Zhe Cheng China

Jiyoung Shin South Korea

Kimberly A. Foster United States

Jung‐Taek Kwon South Korea

Cheng Xu

759 ×1.3

MB

219 ×0.7

BIOMA

290 ×1.0

BE

132 ×0.6

CR

351 ×1.6

HTM

Citations per year, relative to Cheng Xu Cheng Xu (= 1×) peers Jung‐Taek Kwon

Countries citing papers authored by Cheng Xu

Since Specialization

Citations

This map shows the geographic impact of Cheng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Xu more than expected).

Fields of papers citing papers by Cheng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Xu. The network helps show where Cheng Xu may publish in the future.

Co-authorship network of co-authors of Cheng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Xu. A scholar is included among the top collaborators of Cheng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Xu. Cheng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Xu, Cheng, et al.. (2024). Hsa_Circ_0008035 drives immune evasion of gastric cancer via promoting EXT1-mediated nuclear translocation of PKM2. Translational Oncology. 48. 102004–102004. 2 indexed citations

2.

Xu, Cheng, et al.. (2024). Plasma circulating tumor DNA unveils the efficacy of PD-1 inhibitors and chemotherapy in advanced gastric cancer. Scientific Reports. 14(1). 14027–14027. 6 indexed citations

3.

Yu, Yang, et al.. (2023). Maximakinin reduced intracellular Ca2+ level in vascular smooth muscle cells through AMPK/ERK1/2 signaling pathways. Hypertension Research. 46(8). 1949–1960. 3 indexed citations

4.

Xu, Cheng, et al.. (2020). In Vitro-In Vivo Correlation for Solid Dispersion of a Poorly Water-Soluble Drug Efonidipine Hydrochloride. AAPS PharmSciTech. 21(5). 160–160. 13 indexed citations

5.

Xu, Cheng, Baosheng Liu, & Hongcai Zhang. (2019). Study on the Binding Rate of Oral Drugs with Pepsin and Trypsin. 1 indexed citations

6.

Wang, Cheng, et al.. (2019). MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147. BMC Cancer. 19(1). 577–577. 28 indexed citations

7.

Zhou, Lei, Quanyi Wang, Jianyun Li, et al.. (2019). Isolated Cases of Plague — Inner Mongolia-Beijing, 2019. China CDC Weekly. 1(1). 13–16. 13 indexed citations

8.

Zheng, Nan, et al.. (2017). Mesoporous silica nanorods for improved oral drug absorption. Artificial Cells Nanomedicine and Biotechnology. 46(6). 1132–1140. 58 indexed citations

9.

Xu, Jinghua, et al.. (2017). Fluid Retention Caused by Rosiglitazone Is Related to Increases in AQP2 andαENaC Membrane Expression. PPAR Research. 2017. 1–14. 3 indexed citations

10.

Xie, X. C., Wei Chen, Ning Zhang, et al.. (2017). Selective Tissue Distribution Mediates Tissue-Dependent PPARγ Activation and Insulin Sensitization by INT131, a Selective PPARγ Modulator. Frontiers in Pharmacology. 8. 317–317. 10 indexed citations

11.

Lin, Yan, Cheng Xu, Jiude Mao, et al.. (2016). Effects of different dietary n-6/n-3 polyunsaturated fatty acid ratios on boar reproduction. Lipids in Health and Disease. 15(1). 31–31. 26 indexed citations

12.

Yuan, Yue, Cheng Xu, Shengguo Zhao, et al.. (2016). Effects of tail docking on the expression of genes related to lipid metabolism in Lanzhou fat-tailed sheep. Genetics and Molecular Research. 15(1). 6 indexed citations

13.

Ju, Cheng, et al.. (2014). Relationship between human plague epidemic and meteorological factors in China. Chin J Endemiol. 33(5). 488–491. 1 indexed citations

14.

Fleiter, Judy, et al.. (2013). Alcohol-related driving offences, crashes, and traffic policing strategies in Zhejiang Province, China. QUT ePrints (Queensland University of Technology). 2 indexed citations

15.

Urasaki, Yasuyo, et al.. (2012). Coupling of Glucose Deprivation with Impaired Histone H2B Monoubiquitination in Tumors. PLoS ONE. 7(5). e36775–e36775. 81 indexed citations

16.

Xu, Lingfen, et al.. (2011). Disruption of the F-actin cytoskeleton and monolayer barrier integrity induced by PAF and the protective effect of ITF on intestinal epithelium. Archives of Pharmacal Research. 34(2). 245–251. 20 indexed citations

17.

Gao, Zhen & Cheng Xu. (2010). Glucose metabolism induces mono-ubiquitination of histone H2B in mammalian cells. Biochemical and Biophysical Research Communications. 404(1). 428–433. 17 indexed citations

18.

Zhou, Xinbo, Wei Chen, Cheng Xu, et al.. (2010). (S)-3-(4-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)-2-(piperazin-1-yl)propanoic acid compounds: Synthesis and biological evaluation of dual PPARα/γ agonists. Bioorganic & Medicinal Chemistry Letters. 20(8). 2605–2608. 1 indexed citations

19.

Xu, Cheng, et al.. (2006). A novel dual peroxisome proliferator-activated receptors α and γ agonist with beneficial effects on insulin resistance and lipid metabolism. Biotechnology Letters. 28(12). 863–868. 6 indexed citations

20.

Jin, Yaqing, et al.. (2005). Familial aggregation of lung cancer in a high incidence area in China. British Journal of Cancer. 92(7). 1321–1325. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact